Opioid use in pregnancy has more than doubled, per California data
Add Axios as your preferred source to
see more of our stories on Google.

Illustration: Sarah Grillo/Axios
The rate of opioid use in pregnancy more than doubled in 12 years, a new Oregon Health & Science University study using California hospital data found.
Why it matters: Researchers warn the sharp rise puts both mothers and babies at risk — increasing the chance for negative complications such as hypertension, respiratory distress, preterm birth, infant withdrawal syndrome and death.
The big picture: The data, collected between 2008 and 2020, likely underestimates today's danger as the opioid crisis has since worsened in many parts across the country.
- "The real situation is more dire and more severe," Jaime Lo, an associate professor of obstetrics and gynecology at OHSU and the study's lead author, told Axios.
- Between the lines: Across San Diego County, accidental drug overdose deaths spiked during the pandemic and then dropped for three straight years.
What they did: Hoping to better understand the prevalence of opioid use in pregnancy and its potential health outcomes, researchers analyzed hospital data encompassing more than 5.5 million patients in California over the course of 12 years.
- Lo said her team zeroed in on the state due to its diverse age, racial and ethnic demographic makeup, which makes the study's findings "more representative" of the broader U.S. population.
By the numbers: OHSU's analysis found the prevalence of an opioid-related diagnosis in pregnancy rose from 0.14% in 2008 to 0.33% in 2020 — from roughly 700 patients to nearly 1,200, respectively.
State of play: Lo said outcomes for pregnant patients with opioid use disorder and babies remain poor because of the lack of widespread multidisciplinary care — like medication-assisted treatment, mental health support and coordinated obstetric and pediatric services.
- Provider stigma, referral barriers and a shortage of clinicians trained in both addiction medicine and pregnancy care mean patients can often fall through the cracks, she added.
Zoom in: UC San Diego Health provides medication-based opioid and substance use disorder treatment for pregnant individuals during prenatal care and through delivery and postpartum, according to a 2024 presentation.
- There are also at least nine publicly funded treatment programs for pregnant women and moms in San Diego County.
The bottom line: Rising rates aren't irreversible. Outcomes can improve when medical systems invest in perinatal addiction programs, Lo said.
- "That's how we can really turn this conversation around and start to see some of those numbers that are rising turn the other way."

